Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.
Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations section updated with new trial sites across multiple countries, including the United States (many states) and international regions. Some previously listed locations were removed.SummaryDifference2%
- Check21 days agoChange DetectedAdded Gūrgaon, India, 122001 and 122002 as location entries and removed Gurgaon, India, 122001 and 122002. The city name is now displayed with the diacritic.SummaryDifference0.0%
- Check43 days agoChange DetectedPublications section wording updated to clarify auto-filled PubMed entries. Revision note updated to v3.3.2 (instead of v3.2.0).SummaryDifference0.0%
- Check50 days agoChange DetectedRemoved a government funding operating status notice from the page; no trial-specific information is affected.SummaryDifference0.1%
- Check64 days agoChange DetectedAdded Gurgaon, India, 122001 and 122002 to the Locations list and removed Gūrgaon, India, 122001 and 122002 to standardize spelling.SummaryDifference0.2%
- Check93 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference2%
Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.